TY -的A2 Wirth曼弗雷德·p·盟——Røder m . Andreas AU - Berg Kasper d . AU - Gruschy丽莎盟——Brasso克劳斯盟——球队,彼得PY - 2011 DA - 2010/12/22 TI -第一个丹麦单一机构根治性前列腺切除术的经验:1200个连续的患者生化结果SP - 236357六世- 2011 AB -激进retropubic前列腺切除术(RRP)预期治疗治疗患者临床局限性前列腺癌(PC)在丹麦于1995年发起。本文报告单一机构1200个连续的患者结果从第一运营15年期间。在手术年龄中位数为63年。PSA值中位数为9 ng / mL。明显的肿瘤(≤cT2)出现在48%的病人。格里森评分在活检≤7 85%的病人。在百分之六十五的患者中,组织病理学显示本地化PCa RRP之后。积极的外科利润率在39.2%的情况下被发现。生化复发(BR)对214名(18%)患者发生。估计生化无复发生存(BRFS) 5和10年后,71.7%和63.2%。 When patients were stratified according to the D'Amico criteria, BRFS after 10 years was 75.3%, 59.7%, and 39.3% for low-, medium- and high-risk patients, respectively. In univariate analysis, clinical stage, PSA at diagnosis and type of surgery were significant predictors of BR. In multivariate analysis, Gleason score > 7, PSA > 10, and higher clinical stage were significant predictors of BR. Early Danish results in a population not subjected to screening demonstrate BRFS rates comparable with earlier reports from the prescreening era. SN - 2090-3111 UR - https://doi.org/10.1155/2011/236357 DO - 10.1155/2011/236357 JF - Prostate Cancer PB - Hindawi Publishing Corporation KW - ER -